The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity
Open accessAbstract
Hepatitis C virus (HCV) is a global epidemic manifested mainly by chronic infection. One strategy that HCV employs to establish chronic infection is to use the viral Ser protease NS3/4A to cleave some unknown cellular targets involved in innate immunity. Here we show that the target of NS3/4A is the mitochondrial antiviral signaling protein, MAVS, that activates NF-κB and IFN regulatory factor 3 to induce type-I interferons. NS3/4A cleaves MAVS at Cys-508, resulting in the dislocation of the N-terminal fragment of MAVS from the mitochondria. Remarkably, a point mutation of MAVS at Cys-508 renders MAVS resistant to cleavage by NS3/4A, thus maintaining the ability of MAVS to induce interferons in HCV replicon cells. NS3/4A binds to and colocalizes with MAVS in the mitochondrial membrane, and it can cleave MAVS directly in vitro . These results provide an example of host–pathogen interaction in which the virus evades innate immunity by dislodging a pivotal antiviral protein from the mitochondria and suggest that blocking the cleavage of MAVS by NS3/4A may be applied to the prevention and treatment of HCV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Akira, S., & Takeda, K. (2004) · Nature reviews. Immunology · doi:10.1038/nri1391 · Cited by 8,312
Yoneyama, M., Kikuchi, M., Natsukawa, T., Shinobu, N., Imaizumi, T., Miyagishi, M., Taira, K., Akira, S., & Fujita, T. (2004) · Nature Immunology · doi:10.1038/ni1087 · Cited by 3,929
Seth, R. B., Sun, L., Ea, C.-K., & Chen, Z. J. (2005) · Cell · doi:10.1016/j.cell.2005.08.012 · Cited by 3,329
Self-citationReplication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line
Lohmann, V., Körner, F., Koch, J.-O., Herian, U., Theilmann, L., & Bartenschlager, R. (1999) · Science · doi:10.1126/science.285.5424.110 · Cited by 2,814
IKKε and TBK1 are essential components of the IRF3 signaling pathway
Fitzgerald, K. A., McWhirter, S. M., Faia, K. L., Rowe, D. C., Latz, E., Golenbock, D. T., Coyle, A. J., Liao, S.-M., & Maniatis, T. (2003) · Nature Immunology · doi:10.1038/ni921 · Cited by 2,676
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
Kawai, T., Takahashi, K., Sato, S., Coban, C., Kumar, H., Kato, H., Ishii, K. J., Takeuchi, O., & Akira, S. (2005) · Nature Immunology · doi:10.1038/ni1243 · Cited by 2,562
Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus
Meylan, E., Curran, J., Hofmann, K., Moradpour, D., Binder, M., Bartenschlager, R., & Tschopp, J. (2005) · Nature · doi:10.1038/nature04193 · Cited by 2,401
IRF-7 is the master regulator of type-I interferon-dependent immune responses
Honda, K., Yanai, H., Negishi, H., Asagiri, M., Sato, M., Mizutani, T., Shimada, N., Ohba, Y., Takaoka, A., Yoshida, N., et al. (2005) · Nature · doi:10.1038/nature03464 · Cited by 2,245
Decoding the Patterns of Self and Nonself by the Innate Immune System
Medzhitov, R., & Janeway, C. A. (2002) · Science · doi:10.1126/science.1068883 · Cited by 2,154
TAK1 is a ubiquitin-dependent kinase of MKK and IKK
Wang, C., Deng, L., Hong, M., Akkaraju, G. R., Inoue, J.-I., & Chen, Z. J. (2001) · Nature · doi:10.1038/35085597 · Cited by 2,125
Self-citation
Cited by
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling
O'Neill, L. A. J., & Bowie, A. G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2079 · Cited by 2,667
Randall, R. E., & Goodbourn, S. (2008) · Journal of General Virology · doi:10.1099/vir.0.83391-0 · Cited by 1,571
Mitochondria in innate immune responses
West, A. P., Shadel, G. S., & Ghosh, S. (2011) · Nature Reviews Immunology · doi:10.1038/nri2975 · Cited by 1,376
Hou, F., Sun, L., Zheng, H., Skaug, B., Jiang, Q.-X., & Chen, Z. J. (2011) · Cell · doi:10.1016/j.cell.2011.06.041 · Cited by 1,282
Self-citationInnate immunity to virus infection
Takeuchi, O., & Akira, S. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00737.x · Cited by 1,229
Intracellular pattern recognition receptors in the host response
Meylan, E., Tschopp, J., & Karin, M. (2006) · Nature · doi:10.1038/nature04946 · Cited by 1,206
Innate Immune Sensing and Signaling of Cytosolic Nucleic Acids
Wu, J., & Chen, Z. J. (2014) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032713-120156 · Cited by 1,183
Self-citationToll-like receptors and innate immunity
Kumar, H., Kawai, T., & Akira, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.062 · Cited by 1,173
Gitlin, L., Barchet, W., Gilfillan, S., Cella, M., Beutler, B., Flavell, R. A., Diamond, M. S., & Colonna, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0603082103 · Cited by 1,169
The immunology of hepatocellular carcinoma
Ringelhan, M., Pfister, D., O’Connor, T., Pikarsky, E., & Heikenwalder, M. (2018) · Nature Immunology · doi:10.1038/s41590-018-0044-z · Cited by 1,076
Toll‐like Receptor and RIG‐1‐like Receptor Signaling
Kawai, T., & Akira, S. (2008) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1443.020 · Cited by 986
Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens
Finlay, B. B., & McFadden, G. (2006) · Cell · doi:10.1016/j.cell.2006.01.034 · Cited by 904
Goubau, D., Deddouche, S., & Reis e Sousa, C. (2013) · Immunity · doi:10.1016/j.immuni.2013.05.007 · Cited by 843
Mitochondrial Dysfunction and Signaling in Chronic Liver Diseases
Mansouri, A., Gattolliat, C.-H., & Asselah, T. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.083 · Cited by 812
TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity
Creagh, E. M., & O’Neill, L. A. J. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.06.003 · Cited by 762
Structural Basis for the Activation of Innate Immune Pattern-Recognition Receptor RIG-I by Viral RNA
Kowalinski, E., Lunardi, T., McCarthy, A. A., Louber, J., Brunel, J., Grigorov, B., Gerlier, D., & Cusack, S. (2011) · Cell · doi:10.1016/j.cell.2011.09.039 · Cited by 689
The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma
Donne, R., & Lujambio, A. (2023) · Hepatology · doi:10.1002/hep.32740 · Cited by 631
The Specific and Essential Role of MAVS in Antiviral Innate Immune Responses
Sun, Q., Sun, L., Liu, H.-H., Chen, X., Seth, R. B., Forman, J., & Chen, Z. J. (2006) · Immunity · doi:10.1016/j.immuni.2006.04.004 · Cited by 606
Self-citationThe Atg5–Atg12 conjugate associates with innate antiviral immune responses
Jounai, N., Takeshita, F., Kobiyama, K., Sawano, A., Miyawaki, A., Xin, K.-Q., Ishii, K. J., Kawai, T., Akira, S., Suzuki, K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0704014104 · Cited by 565
Living in the liver: hepatic infections
Protzer, U., Maini, M. K., & Knolle, P. A. (2012) · Nature Reviews Immunology · doi:10.1038/nri3169 · Cited by 560
Rules of engagement: molecular insights from host–virus arms races
Daugherty, M. D., & Malik, H. S. (2012) · Annual Review of Genetics · doi:10.1146/annurev-genet-110711-155522 · Cited by 515
Frieman, M., Yount, B., Heise, M., Kopecky-Bromberg, S. A., Palese, P., & Baric, R. S. (2007) · Journal of Virology · doi:10.1128/jvi.01012-07 · Cited by 507
TCR–peptide–MHC interactions in situ show accelerated kinetics and increased affinity
Huppa, J. B., Axmann, M., Mörtelmaier, M. A., Lillemeier, B. F., Newell, E. W., Brameshuber, M., Klein, L. O., Schütz, G. J., & Davis, M. M. (2010) · Nature · doi:10.1038/nature08746 · Cited by 504
Essential role of IPS-1 in innate immune responses against RNA viruses
Kumar, H., Kawai, T., Kato, H., Sato, S., Takahashi, K., Coban, C., Yamamoto, M., Uematsu, S., Ishii, K. J., Takeuchi, O., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20060792 · Cited by 504
Antiviral innate immunity pathways
Seth, R. B., Sun, L., & Chen, Z. J. (2006) · Cell Research · doi:10.1038/sj.cr.7310019 · Cited by 494
Self-citationDreux, M., Garaigorta, U., Boyd, B., Décembre, E., Chung, J., Whitten-Bauer, C., Wieland, S., & Chisari, F. V. (2012) · Cell Host & Microbe · doi:10.1016/j.chom.2012.08.010 · Cited by 475
Shi, C.-S., Qi, H.-Y., Boularan, C., Huang, N.-N., Abu-Asab, M., Shelhamer, J. H., & Kehrl, J. H. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1303196 · Cited by 473
Antiviral Signaling Through Pattern Recognition Receptors
Kawai, T., & Akira, S. (2006) · Journal of Biochemistry · doi:10.1093/jb/mvm032 · Cited by 451
Viral evasion of intracellular DNA and RNA sensing
Chan, Y. K., & Gack, M. U. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.45 · Cited by 450
Detection of Microbial Infections Through Innate Immune Sensing of Nucleic Acids
Tan, X., Sun, L., Chen, J., & Chen, Z. J. (2018) · Annual Review of Microbiology · doi:10.1146/annurev-micro-102215-095605 · Cited by 443
Self-citationToll-like receptors and innate immunity
Uematsu, S., & Akira, S. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0084-y · Cited by 441
Besch, R., Poeck, H., Hohenauer, T., Senft, D., Häcker, G., Berking, C., Hornung, V., Endres, S., Ruzicka, T., Rothenfusser, S., et al. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37155 · Cited by 433
Ten Strategies of Interferon Evasion by Viruses
García-Sastre, A. (2017) · Cell Host & Microbe · doi:10.1016/j.chom.2017.07.012 · Cited by 423
Dissecting negative regulation of Toll-like receptor signaling
Kondo, T., Kawai, T., & Akira, S. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.05.002 · Cited by 419
Interferons and viruses: an evolutionary arms race of molecular interactions
Hoffmann, H.-H., Schneider, W. M., & Rice, C. M. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.01.004 · Cited by 410
Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5
Reikine, S., Nguyen, J. B., & Modis, Y. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00342 · Cited by 410
Modulation of NF-κB signalling by microbial pathogens
Rahman, M. M., & McFadden, G. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2539 · Cited by 400
Toll-Like Receptors and RNA Helicases: Two Parallel Ways to Trigger Antiviral Responses
Meylan, E., & Tschopp, J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.012 · Cited by 372
The role of ubiquitylation in immune defence and pathogen evasion
Jiang, X., & Chen, Z. J. (2012) · Nature Reviews Immunology · doi:10.1038/nri3111 · Cited by 353
Self-citationRecognition of viruses by innate immunity
Takeuchi, O., & Akira, S. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00562.x · Cited by 342
Lemon, S. M., Ott, J. J., Van Damme, P., & Shouval, D. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2017.08.034 · Cited by 336
Ke, P.-Y., & Chen, S. S.-L. (2011) · Journal of Clinical Investigation · doi:10.1172/jci41474 · Cited by 336
Fredericksen, B. L., Keller, B. C., Fornek, J., Katze, M. G., & Gale, M. (2008) · Journal of Virology · doi:10.1128/jvi.01305-07 · Cited by 327
Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor
Yang, Y., Liang, Y., Qu, L., Chen, Z., Yi, M., Li, K., & Lemon, S. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611506104 · Cited by 320
Self-citationApoptotic Caspases Suppress Type I Interferon Production via the Cleavage of cGAS, MAVS, and IRF3
Ning, X., Wang, Y., Jing, M., Sha, M., Lv, M., Gao, P., Zhang, R., Huang, X., Feng, J.-M., & Jiang, Z. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.02.013 · Cited by 317
Flying Under the Radar: The Immunobiology of Hepatitis C
Dustin, L. B., & Rice, C. M. (2007) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141602 · Cited by 313
Changes in Glutathione Content in Liver Diseases: An Update
Vairetti, M., Di Pasqua, L. G., Cagna, M., Richelmi, P., Ferrigno, A., & Berardo, C. (2021) · Antioxidants · doi:10.3390/antiox10030364 · Cited by 313
Function of RIG-I-like Receptors in Antiviral Innate Immunity
Yoneyama, M., & Fujita, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.r700007200 · Cited by 311
Liver diseases: epidemiology, causes, trends and predictions
Gan, C., Yuan, Y., Shen, H., Gao, J., Kong, X., Che, Z., Guo, Y., Wang, H., Dong, E., & Xiao, J. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-02072-z · Cited by 310
Deubiquitinating and Interferon Antagonism Activities of Coronavirus Papain-Like Proteases
Clementz, M. A., Chen, Z., Banach, B. S., Wang, Y., Sun, L., Ratia, K., Baez-Santos, Y. M., Wang, J., Takayama, J., Ghosh, A. K., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02406-09 · Cited by 308
Self-citationTRADD Protein Is an Essential Component of the RIG-like Helicase Antiviral Pathway
Michallet, M.-C., Meylan, E., Ermolaeva, M. A., Vazquez, J., Rebsamen, M., Curran, J., Poeck, H., Bscheider, M., Hartmann, G., König, M., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.03.013 · Cited by 306
Mukherjee, A., Morosky, S. A., Delorme-Axford, E., Dybdahl-Sissoko, N., Oberste, M. S., Wang, T., & Coyne, C. B. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1001311 · Cited by 305
mda-5, but not RIG-I, is a common target for paramyxovirus V proteins
Childs, K., Stock, N., Ross, C., Andrejeva, J., Hilton, L., Skinner, M., Randall, R., & Goodbourn, S. (2007) · Virology · doi:10.1016/j.virol.2006.09.023 · Cited by 301
Interferon regulatory factor 1 (IRF1) and anti-pathogen innate immune responses
Feng, H., Zhang, Y.-B., Gui, J.-F., Lemon, S. M., & Yamane, D. (2021) · PLOS Pathogens · doi:10.1371/journal.ppat.1009220 · Cited by 289
Regulation of hepatic innate immunity by hepatitis C virus
Horner, S. M., & Gale, M. (2013) · Nature Medicine · doi:10.1038/nm.3253 · Cited by 278
Sun, L., Xing, Y., Chen, X., Zheng, Y., Yang, Y., Nichols, D. B., Clementz, M. A., Banach, B. S., Li, K., Baker, S. C., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0030802 · Cited by 268
Self-citationInnate immune evasion strategies of DNA and RNA viruses
Beachboard, D. C., & Horner, S. M. (2016) · Current Opinion in Microbiology · doi:10.1016/j.mib.2016.05.015 · Cited by 265
Dengue Virus Targets the Adaptor Protein MITA to Subvert Host Innate Immunity
Yu, C.-Y., Chang, T.-H., Liang, J.-J., Chiang, R.-L., Lee, Y.-L., Liao, C.-L., & Lin, Y.-L. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002780 · Cited by 259
Mitochondrial Membrane Potential Is Required for MAVS-Mediated Antiviral Signaling
Koshiba, T., Yasukawa, K., Yanagi, Y., & Kawabata, S.-I. (2011) · Science Signaling · doi:10.1126/scisignal.2001147 · Cited by 257
Viral tricks to grid-lock the type I interferon system
Versteeg, G. A., & García-Sastre, A. (2010) · Current Opinion in Microbiology · doi:10.1016/j.mib.2010.05.009 · Cited by 256
Mitofusin 2 Inhibits Mitochondrial Antiviral Signaling
Yasukawa, K., Oshiumi, H., Takeda, M., Ishihara, N., Yanagi, Y., Seya, T., Kawabata, S.-I., & Koshiba, T. (2009) · Science Signaling · doi:10.1126/scisignal.2000287 · Cited by 255
Hilton, L., Moganeradj, K., Zhang, G., Chen, Y.-H., Randall, R. E., McCauley, J. W., & Goodbourn, S. (2006) · Journal of Virology · doi:10.1128/jvi.01145-06 · Cited by 253
Convergent evolution of escape from hepaciviral antagonism in primates
Patel, M. R., Loo, Y.-M., Horner, S. M., Gale, M., & Malik, H. S. (2012) · PLoS Biology · doi:10.1371/journal.pbio.1001282 · Cited by 95
“This inhibition is specific to the HCV protease-mediated proteolysis at residue 508, since introducing a C508R mutation in human MAVS blocks this inhibition, as shown previously (Figure 2A) [8].”
MethodVISA—A pass to innate immunity
Qi, B., Huang, Y., Rowe, D., & Halliday, G. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.08.016 · Cited by 18
Do mitochondria have an immune system?
Popkov, V. A., Zorova, L. D., Korvigo, I. O., Silachev, D. N., Jankauskas, S. S., Babenko, V. A., Pevzner, I. B., Danilina, T. I., Zorov, S. D., Plotnikov, E. Y., et al. (2016) · Biochemistry (Moscow) · doi:10.1134/s0006297916100217 · Cited by 5
Metadata
- Authors
- Li, X.-D., Sun, L., Seth, R. B., Pineda, G., & Chen, Z. J.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2005-11-21
- Volume
- 102
- Issue
- 49
- Pages
- 17717-17722
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2013092102
- Cited by
- 840
- References
- 44
- FWCI
- 22.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.